Cargando…
Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy
This study presents the early framework of selective cell tagging (SeCT) therapy, which is the concept of preferentially labeling specific cells in vivo with chemical moieties that can elicit a therapeutic response. Using glycosylated artificial metalloenzyme (GArM)–based protein labeling, this stud...
Autores principales: | Vong, Kenward, Tahara, Tsuyoshi, Urano, Sayaka, Nasibullin, Igor, Tsubokura, Kazuki, Nakao, Yoichi, Kurbangalieva, Almira, Onoe, Hirotaka, Watanabe, Yasuyoshi, Tanaka, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064634/ https://www.ncbi.nlm.nih.gov/pubmed/33893089 http://dx.doi.org/10.1126/sciadv.abg4038 |
Ejemplares similares
-
Pattern Recognition: Sequential Double “Clicks” toward Structurally Well‐Defined Heterogeneous N‐Glycoclusters: The Importance of Cluster Heterogeneity on Pattern Recognition In Vivo (Adv. Sci. 2/2017)
por: Latypova, Liliya, et al.
Publicado: (2017) -
Sequential Double “Clicks” toward Structurally Well‐Defined Heterogeneous N‐Glycoclusters: The Importance of Cluster Heterogeneity on Pattern Recognition In Vivo
por: Latypova, Liliya, et al.
Publicado: (2016) -
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression
por: Nasibullin, Igor, et al.
Publicado: (2022) -
In vivo metal-catalyzed SeCT therapy by a proapoptotic peptide
por: Ahmadi, Peni, et al.
Publicado: (2021) -
Homo- and Heterogeneous Glycoconjugates on the Basis of N-Glycans and Human Serum Albumin: Synthesis and Biological Evaluation
por: Kurbangalieva, Almira, et al.
Publicado: (2022)